Hua Medicine’s dorzagliatin wins Hong Kong approval: what the glucokinase activator milestone means for diabetes treatment
Hua Medicine’s dorzagliatin wins Hong Kong approval for Type 2 diabetes. Discover what this glucokinase activator milestone means for global diabetes treatment.